Cargando…

Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice

BACKGROUND: Alzheimer’s disease is widely described since the discovery of histopathological lesions in Mrs. Auguste Deter in 1906. However to date, there is no effective treatment to deal with the many cellular and molecular alterations. The complexity is even higher with the growing evidence of in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vérité, J., Janet, T., Chassaing, D., Fauconneau, B., Rabeony, H., Page, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001165/ https://www.ncbi.nlm.nih.gov/pubmed/29898739 http://dx.doi.org/10.1186/s12974-018-1220-7

Ejemplares similares

Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer’s patients in a human blood brain barrier model
por: Vérité, Julie, et al.
Publicado: (2018)

Longitudinal follow-up of autophagy and inflammation in brain of APPswePS1dE9 transgenic mice
por: François, Arnaud, et al.
Publicado: (2014)

Natural stilbenes effects in animal models of Alzheimer’s disease
por: Freyssin, Aline, et al.
Publicado: (2019)

Trans ε viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model
por: Caillaud, Martial, et al.
Publicado: (2019)

Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases
por: Freyssin, Aline, et al.
Publicado: (2018)

Chemokine Actions in the CNS: Insights from Transgenic Mice
por: Müller, Marcus, et al.
Publicado: (2008)

Maternal imprinting on cognition markers of wild type and transgenic Alzheimer’s disease model mice
por: Zamarbide, Marta, et al.
Publicado: (2018)

Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines
por: Ott, Brian R., et al.
Publicado: (2018)

Identifying Blood Transcriptome Biomarkers of Alzheimer’s Disease Using Transgenic Mice
por: Ochi, Shinichiro, et al.
Publicado: (2020)

Increased Abscess Formation and Defective Chemokine Regulation in CREB Transgenic Mice
por: Wen, Andy Y., et al.
Publicado: (2013)

Regulation of Inflammatory Chemokine Receptors on Blood T Cells Associated to the Circulating Versus Liver Chemokines in Dengue Fever
por: de-Oliveira-Pinto, Luzia Maria, et al.
Publicado: (2012)

Delta-secretase triggers Alzheimer’s disease pathologies in wild-type hAPP/hMAPT double transgenic mice
por: Wu, Zhourui, et al.
Publicado: (2020)

Inflammatory Stress on Autophagy in Peripheral Blood Mononuclear Cells from Patients with Alzheimer's Disease during 24 Months of Follow-Up
por: François, Arnaud, et al.
Publicado: (2015)

Chemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
por: Zuena, Anna Rita, et al.
Publicado: (2019)

The blood-brain barrier in Alzheimer's disease
por: Zenaro, Elena, et al.
Publicado: (2017)

Metabolic profiling of a transgenic Caenorhabditis elegans Alzheimer model
por: Van Assche, Roel, et al.
Publicado: (2014)

Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model
por: Freyssin, Aline, et al.
Publicado: (2022)

A novel transgenic zebrafish model for blood-brain and blood-retinal barrier development
por: Xie, Jing, et al.
Publicado: (2010)

Transgenic animal models to explore and modulate the blood brain and blood retinal barriers of the CNS
por: Goncalves, Andreia, et al.
Publicado: (2022)

Changes in Chemokines and Chemokine Receptors Expression in a Mouse Model of Alzheimer's Disease
por: Jorda, Adrián, et al.
Publicado: (2019)

Correction: Inflammatory Stress on Autophagy in Peripheral Blood Mononuclear Cells from Patients with Alzheimer's Disease during 24 Months of Follow-Up
por: François, Arnaud, et al.
Publicado: (2016)

Redox Proteomic Profiling of Specifically Carbonylated Proteins in the Serum of Triple Transgenic Alzheimer’s Disease Mice
por: Shen, Liming, et al.
Publicado: (2016)

The Consumption of Energy Drinks Induces Blood-Brain Barrier Dysfunction in Wild-Type Mice
por: Graneri, Liam, et al.
Publicado: (2021)

Longitudinal Metabolomics Profiling of Parkinson’s Disease-Related α-Synuclein A53T Transgenic Mice
por: Chen, Xi, et al.
Publicado: (2015)

Blood–brain-barriers in aging and in Alzheimer’s disease
por: Marques, Fernanda, et al.
Publicado: (2013)

Longitudinal investigation of neuroinflammation and metabolite profiles in the APP (swe)×PS1(Δe9) transgenic mouse model of Alzheimer's disease
por: Chaney, Aisling, et al.
Publicado: (2017)

Endotoxin-induced cytokine and chemokine expression in the HIV-1 transgenic rat
por: Homji, Natasha F, et al.
Publicado: (2012)

Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington’s disease monkeys
por: Kocerha, Jannet, et al.
Publicado: (2013)

Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer’s disease
por: Boyanova, Sevda T., et al.
Publicado: (2023)

The role of cytokines and chemokines in the microenvironment of the blood–brain barrier in leukemia central nervous system metastasis
por: Si, Mengya, et al.
Publicado: (2018)

Chemokine CXCL13 in serum, CSF and blood–CSF barrier function: evidence of compartment restriction
por: Pilz, Georg, et al.
Publicado: (2020)

Role of Chemokines in the Development and Progression of Alzheimer’s Disease
por: Wojcieszak, Jakub, et al.
Publicado: (2022)

Ceramide and Related-Sphingolipid Levels Are Not Altered in Disease-Associated Brain Regions of APP(SL) and APP(SL)/PS1(M146L) Mouse Models of Alzheimer's Disease: Relationship with the Lack of Neurodegeneration?
por: Barrier, Laurence, et al.
Publicado: (2010)

Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer’s disease
por: Llibre-Guerra, Jorge J, et al.
Publicado: (2023)

Reactive or transgenic increase in microglial TYROBP reveals a TREM2‐independent TYROBP–APOE link in wild‐type and Alzheimer's‐related mice
por: Audrain, Mickael, et al.
Publicado: (2020)

Dyslipidemia and Blood-Brain Barrier Integrity in Alzheimer's Disease
por: Bowman, Gene L., et al.
Publicado: (2012)

Disruption of blood-brain barrier in Alzheimer disease pathogenesis
por: Kook, Sun-Young, et al.
Publicado: (2013)

Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease
por: Yamazaki, Yu, et al.
Publicado: (2017)

Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease
por: Sharma, Chanchal, et al.
Publicado: (2022)

Expression of Phenotypic Astrocyte Marker Is Increased in a Transgenic Mouse Model of Alzheimer's Disease versus Age-Matched Controls: A Presymptomatic Stage Study
por: Doméné, Aurélie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u8cumgpom4clv4pd0g8jjla4m2